Appendix Table 2:
Treatment of Emergency department and observation patients with COVID19 infection
| COVID positive (n=7) | COVID negative (n=123) | P Value | |
|---|---|---|---|
| Treatment | |||
| Doxycycline | 2/7 (29%) | 13/123 (11%) | 0.186 |
| Fluoroquinolones | 0/7 (0%) | 3/123 (2%) | 1.00 |
| Azithromycin | 2/7 (29%) | 4/123 (3%) | 0.033 |
| Cephalosporin | 1/7 (14%) | 4/123 (3%) | 0.245 |
| TMP-SMX | 0/7 (0%) | 2/123 (2%) | 1.00 |
| Oseltamivir | 0/7 (0%) | 4/123 (3%) | 1.00 |
| No antimicrobials given on dc | 3/7(43%) | 100/123 (80%) | 0.041 |
| Respiratory support | |||
| High Flow | 0/7 (0%) | 0/123(0%) | -- |
| Crystalloid bolus volume within first 24 hours (mean, SD) | 1000 (0) n=3 |
1351.4 (716) n=37 |
0.406 |